Immunic Inc (IMUX)
Healthcare
Biotechnology
14.10 $
+0.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Immunic Inc (IMUX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -86 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -41 | -50 | -36 | -40 | -43 | -29 | -46 | -83 | -65 | -71 | -85 | -86 | |
| 1.1 | 1.3 | 1.8 | 1.0 | 0.7 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | |
| 2.5 | 4.0 | 4.7 | 5.5 | 3.7 | 6.5 | 2.7 | 5.9 | 7.9 | 7.1 | 8.5 | 8.9 | |
| 2.5 | 4.0 | 4.8 | 5.7 | 5.2 | 7.7 | 0.2 | 19 | 46 | – | – | – | |
| 5.8 | -3.3 | -1.4 | 4.9 | -7.6 | -1.4 | -2.4 | -9.3 | 9.5 | 15 | 0.6 | 1.8 | |
| 1.4 | 2.3 | 0.6 | 0.7 | 0.6 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.3 | 0.2 | |
| -2.0 | -1.3 | 0.0 | -0.7 | -0.4 | 11 | -0.1 | -0.1 | -9.7 | 9.5 | -0.3 | -0.2 | |
| 4.7 | – | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 107 | 32 | 12 | 38 | 0.0 | 35 | 144 | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | |
| – | – | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 107 | 32 | 12 | 38 | 0.0 | 35 | 144 | 43 | 96 | 1.0 | 75 | 66 | |
| 64 | -19 | -23 | -3.1 | -44 | 16 | 98 | -41 | 20 | -60 | -11 | -20 | |
| -42 | -52 | -36 | -41 | -44 | -29 | -46 | -83 | -65 | -71 | -85 | -86 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.